Program

Friday, September 18th

08:00 – 09:00
Participant registration
09:00 – 09:10
Summer school opening
09:10 – 11:00
Krisztina Herédi-Szabó, Solvo Biotechnology, Hungary
In-vitro transporter technologies

11:00 – 11:15
Coffee break
11:15 – 12:15
Alex Avdeef, In-ADME Research, USA
Both Passive and Carrier-Mediated Uptake are Important in Drug Disposition
12:15 – 13:00
Alex Avdeef, In-ADME Research, USA
Salt Solubility Measurement – Improved Perspectives to an Old Challenge

  Working lunch
15:00 – 16:15
Vesna Gabelica Marković, Fidelta d.o.o., Croatia
Isolation and characterization of impurities in drug development
16:15 – 17:00
Mario Grassi, University of Trieste, Italy
Determination of nanocrystals size distribution in polymer-drug systems

17:00 – 17:25
Coffee break
17:25 – 19:00
Biserka Cetina Čižmek, PLIVA Ltd, Croatia
Analytical methodologies in the formulation development

Saturday, September 19th

09:00 – 11:00
Abu Serajuddin, St. John’s University, USA
Structure of pharma research and different paradigms of drug and formulation development

11:00 – 11:20
Coffee break
11:20 – 13:00
Abu Serajuddin, St. John’s University, USA
Biopharmaceutical roadmap: optimization of clinical drug product performance

  Working lunch
15:00 – 16:45
Rolf Hilfiker, Solvias AG, Switzerland
The importance of choosing the optimal solid form of drug. Salts, co-crystals, polymorphs and solvates. Part 1

16:45 – 17:05
Coffee break
17:05 – 18:15
Rolf Hilfiker, Solvias AG, Switzerland
The importance of choosing the optimal solid form of drug. Salts, co-crystals, polymorphs and solvates. Part 2
18:15 – 19:00
Biserka Cetina Čižmek, PLIVA Ltd, Croatia
Excipients and their compatibility

Sunday, September 20th

09:00 – 09:45
Klara Valko, GlaxoSmithKline, UK
Measurements of bio-mimetic lipophilicity by HPLC
09:45 – 10:30
Klara Valko, GlaxoSmithKline, UK
Models for drug distribution with biomimetic HPLC data

10:30 – 10:50
Coffee break
10:50 – 11:40
Klara Valko, GlaxoSmithKline, UK
Absorption and lipophilicity
11:40 – 13:00
Abu Serajuddin, St. John’s University, USA
Enabling technologies for bioavailability enhancement and dosage form development of poorly water-soluble drugs

  Working lunch
15:00 – 16:45
Christos Reppas, University of Athens, Greece
Choosing the optimal oral dosage form

16:45 – 17:15
Coffee break
17:15 – 18:45
Christos Reppas, University of Athens, Greece
Biorelevant In vitro performance testing of orally administered drug products: Case studies

20:00 - Welcome party, joint ESSDFD-2 and PCMDDD-4 event
Copyright 2009 IAPC